Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Inspira Technologies Oxy BHN ( (IINN) ) has issued an announcement.
Inspira Technologies Oxy B.H.N. Ltd. is preparing to potentially increase production of its INSPIRA™ ART100 device in response to a human metapneumovirus outbreak in China. The company is collaborating with suppliers and health authorities to ensure readiness and rapid deployment of its respiratory care equipment, positioning itself to meet potential demand spikes and aligning with its commitment to global health preparedness.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. is an innovative medical technology company specializing in life support and respiratory treatment solutions. The company has developed the INSPIRA™ ART, a device aimed at revolutionizing the $19 billion mechanical ventilation market by providing an alternative treatment for acute respiratory failure. Key features include the ability to elevate and stabilize oxygen levels without a ventilator, with patients remaining awake, and a HYLA™ blood sensor for real-time monitoring.
YTD Price Performance: -4.76%
Average Trading Volume: 162,602
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.36M
Learn more about IINN stock on TipRanks’ Stock Analysis page.
